Cargando…
Marine Brominated Tyrosine Alkaloids as Promising Inhibitors of SARS-CoV-2
There have been more than 150 million confirmed cases of SARS-CoV-2 since the beginning of the pandemic in 2019. By June 2021, the mortality from such infections approached 3.9 million people. Despite the availability of a number of vaccines which provide protection against this virus, the evolution...
Autores principales: | El-Demerdash, Amr, Hassan, Afnan, Abd El-Aziz, Tarek Mohamed, Stockand, James D., Arafa, Reem K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537272/ https://www.ncbi.nlm.nih.gov/pubmed/34684755 http://dx.doi.org/10.3390/molecules26206171 |
Ejemplares similares
-
Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19)
por: El-Demerdash, Amr, et al.
Publicado: (2021) -
Investigating the structure-activity relationship of marine polycyclic batzelladine alkaloids as promising inhibitors for SARS-CoV-2 main protease (M(pro))
por: Elgohary, Alaa M., et al.
Publicado: (2022) -
Investigating the structure–activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors
por: El-Demerdash, Amr, et al.
Publicado: (2021) -
Investigating the hepatoprotective potentiality of marine-derived steroids as promising inhibitors of liver fibrosis
por: Tammam, Mohamed A., et al.
Publicado: (2023) -
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
por: Abd El-Aziz, Tarek Mohamed, et al.
Publicado: (2020)